4-(3-ISOPROPOXYPHENYL)-1-ISOPROPYLPIPERIDIN-4-OL
![]() |
- $444 - $3529
- Product name: 4-(3-ISOPROPOXYPHENYL)-1-ISOPROPYLPIPERIDIN-4-OL
- CAS: 1198286-60-0
- MF: C17H27NO2
- MW: 277.4
- EINECS:
- MDL Number:MFCD07774826
- Synonyms:4-(3-ISOPROPOXYPHENYL)-1-ISOPROPYLPIPERIDIN-4-OL;4-Piperidinol, 4-[3-(1-methylethoxy)phenyl]-1-(1-methylethyl)-;4-[3-(1-Methylethoxy)phenyl]-1-(1-methylethyl)-4-piperidinol
4 prices
Selected condition:
Brand
- Crysdot
Package
- 1g
- 5g
- 10g
- 25g
- ManufacturerCrysdot
- Product numberCD11333842
- Product description4-(3-Isopropoxyphenyl)-1-isopropylpiperidin-4-ol 97%
- Packaging1g
- Price$444
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11333842
- Product description4-(3-Isopropoxyphenyl)-1-isopropylpiperidin-4-ol 97%
- Packaging5g
- Price$1177
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11333842
- Product description4-(3-Isopropoxyphenyl)-1-isopropylpiperidin-4-ol 97%
- Packaging10g
- Price$1965
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11333842
- Product description4-(3-Isopropoxyphenyl)-1-isopropylpiperidin-4-ol 97%
- Packaging25g
- Price$3529
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD11333842 | 4-(3-Isopropoxyphenyl)-1-isopropylpiperidin-4-ol 97% | 1g | $444 | 2021-12-16 | Buy |
Crysdot | CD11333842 | 4-(3-Isopropoxyphenyl)-1-isopropylpiperidin-4-ol 97% | 5g | $1177 | 2021-12-16 | Buy |
Crysdot | CD11333842 | 4-(3-Isopropoxyphenyl)-1-isopropylpiperidin-4-ol 97% | 10g | $1965 | 2021-12-16 | Buy |
Crysdot | CD11333842 | 4-(3-Isopropoxyphenyl)-1-isopropylpiperidin-4-ol 97% | 25g | $3529 | 2021-12-16 | Buy |
Properties
Boiling point :403.5±45.0 °C(Predicted)
Density :1.040±0.06 g/cm3(Predicted)
pka :14.08±0.20(Predicted)
Density :1.040±0.06 g/cm3(Predicted)
pka :14.08±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|